The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-N-(2-(diethylamino)propyl)-2-(2-methoxyethoxy)-6-(5-(thiophen-2-yl)pyrazolo[1,5-a]pyrimidin-3-yl)isonicotinamide ID: ALA4210881
PubChem CID: 134539892
Max Phase: Preclinical
Molecular Formula: C26H32N6O3S
Molecular Weight: 508.65
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CCN(CC)[C@@H](C)CNC(=O)c1cc(OCCOC)nc(-c2cnn3ccc(-c4cccs4)nc23)c1
Standard InChI: InChI=1S/C26H32N6O3S/c1-5-31(6-2)18(3)16-27-26(33)19-14-22(29-24(15-19)35-12-11-34-4)20-17-28-32-10-9-21(30-25(20)32)23-8-7-13-36-23/h7-10,13-15,17-18H,5-6,11-12,16H2,1-4H3,(H,27,33)/t18-/m0/s1
Standard InChI Key: CNGOYLDTGAKEEQ-SFHVURJKSA-N
Molfile:
RDKit 2D
36 39 0 0 0 0 0 0 0 0999 V2000
26.8022 -9.1418 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.8022 -9.9590 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.5075 -10.3635 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.5075 -8.7291 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.2128 -9.1418 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.2172 -9.9555 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.9923 -10.2036 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.4672 -9.5418 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.9852 -8.8862 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.0245 -10.2069 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3679 -9.7204 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
24.7023 -10.1946 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.9476 -10.9741 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7647 -10.9817 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.9911 -11.0199 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.2814 -11.4272 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.2803 -12.2436 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.9882 -12.6537 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6986 -12.2414 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6962 -11.4263 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.5720 -12.6512 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.8649 -12.2416 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.5709 -13.4684 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.1566 -12.6492 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.4495 -12.2396 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.7412 -12.6472 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.0340 -12.2376 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.7400 -13.4644 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3258 -12.6452 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0317 -13.8720 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.4506 -11.4224 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.4074 -12.6481 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.1140 -12.2377 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.8228 -12.6445 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.5294 -12.2340 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
33.2382 -12.6408 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 4 2 0
2 3 2 0
3 6 1 0
5 4 1 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 5 1 0
10 11 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 10 2 0
2 10 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
7 15 1 0
17 21 1 0
21 22 1 0
21 23 2 0
22 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
26 28 1 0
27 29 1 0
28 30 1 0
25 31 1 1
19 32 1 0
32 33 1 0
33 34 1 0
34 35 1 0
35 36 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 508.65Molecular Weight (Monoisotopic): 508.2257AlogP: 4.01#Rotatable Bonds: 12Polar Surface Area: 93.88Molecular Species: BASEHBA: 9HBD: 1#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: 13.95CX Basic pKa: 9.33CX LogP: 3.89CX LogD: 1.97Aromatic Rings: 4Heavy Atoms: 36QED Weighted: 0.29Np Likeness Score: -2.12
References 1. Koltun DO, Parkhill EQ, Kalla R, Perry TD, Elzein E, Li X, Simonovich SP, Ziebenhaus C, Hansen TR, Marchand B, Hung WK, Lagpacan L, Hung M, Aoyama RG, Murray BP, Perry JK, Somoza JR, Villaseñor AG, Pagratis N, Zablocki JA.. (2018) Discovery of potent and selective inhibitors of calmodulin-dependent kinase II (CaMKII)., 28 (3): [PMID:29254643 ] [10.1016/j.bmcl.2017.10.040 ]